IMPACT Therapeutics scores $10 mln Series B
Chinese drug developer IMPACT Therapeutics raised $10 million in Series B financing. New investors China Summit Capital, Guangzhou YUEXIU Industrial Investment Fund, Sungent Bioventure and HAIBANG Ventures participated in the round along with existing backer Lilly Asia Ventures.
23 February 2016•5 mins read
